Exagen, Inc. (XGN)
8.17
+0.28
(+3.55%)
USD |
NASDAQ |
Oct 02, 16:00
8.14
-0.03
(-0.37%)
After-Hours: 20:00
Exagen EPS Diluted (Quarterly) : -0.1323 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1323 |
| March 31, 2026 | -0.1663 |
| December 31, 2025 | -0.1982 |
| September 30, 2025 | -0.3089 |
| June 30, 2025 | -0.2105 |
| March 31, 2025 | -0.2022 |
| December 31, 2024 | -0.2041 |
| September 30, 2024 | -0.2754 |
| June 30, 2024 | -0.1632 |
| March 31, 2024 | -0.1872 |
| December 31, 2023 | -0.3125 |
| September 30, 2023 | -0.3061 |
| June 30, 2023 | -0.2839 |
| March 31, 2023 | -0.4386 |
| December 31, 2022 | -0.8348 |
| September 30, 2022 | -0.474 |
| June 30, 2022 | -0.8597 |
| March 31, 2022 | -0.6045 |
| December 31, 2021 | -0.4156 |
| September 30, 2021 | -0.4236 |
| June 30, 2021 | -0.3786 |
| March 31, 2021 | -0.4797 |
| December 31, 2020 | -0.2729 |
| Date | Value |
|---|---|
| September 30, 2020 | -0.3407 |
| June 30, 2020 | -0.2661 |
| March 31, 2020 | -0.4417 |
| December 31, 2019 | -0.2713 |
| September 30, 2019 | -11.29 |
| June 30, 2019 | -0.4132 |
| March 31, 2019 | -0.4003 |
| December 31, 2018 | -0.3468 |
| September 30, 2018 | -0.3759 |
| June 30, 2018 | -0.3704 |
| March 31, 2018 | -0.4426 |
| December 31, 2015 | -0.2639 |
| September 30, 2015 | -0.3446 |
| June 30, 2015 | -0.8694 |
| March 31, 2015 | -0.3369 |
| December 31, 2014 | -0.2626 |
| September 30, 2014 | -0.4489 |
| June 30, 2014 | -0.3773 |
| March 31, 2014 | -0.3395 |
| December 31, 2013 | -0.7957 |
| September 30, 2013 | -0.2643 |
| June 30, 2013 | -0.2502 |
| March 31, 2013 | -0.2432 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -0.4557 |
| BioRestorative Therapies, Inc. | -2.431 |
| CareDx, Inc. | 2.071 |
| Natera, Inc. | -0.4674 |
| Sera Prognostics, Inc. | -0.181 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.196M |
| Revenue (Quarterly) | 19.94M |
| Total Expenses (Quarterly) | 23.14M |
| Enterprise Value | 200.73M |
| Gross Profit Margin (Quarterly) | 61.27% |
| Profit Margin (Quarterly) | -16.03% |
| Earnings Yield | -9.86% |
| Normalized Earnings Yield | -9.361 |